Our experienced team and advisors have extensive relationships with both potential portfolio companies and purchasers for exits in the Advanced Therapy (AT) space, providing global coverage and invaluable expertise in key AT developments worldwide.
We prioritize early-stage companies driving innovation in AT technologies, aiming to reduce costs, save time, and enhance accessibility. Our tech-focused strategy capitalizes on our global team's unique strengths and extensive industry experience, granting us a competitive edge in a less saturated market.
We focus on AT-related tools and enabling technologies, including critical reagents, assays, and diagnostics. Additionally, we invest in systems for the manufacturing and logistics supply chain, analytical technologies, and data capture (raw material, in-process, and final release). Machine learning and artificial intelligence are also key areas of our investment focus.
Our fund requires a minimum investment of US$250,000, and our objective is to build a diversified portfolio with 12-15 fund investments. We allocate a quarter of the fund for follow-on investments, and our ongoing engagement is designed to enhance the potential for higher-value exits.
We utilize a global network to source, build, and scale premier portfolio companies. With a strong track record and active relationships with 100+ key players in the global AT arena, we are well-positioned to drive success.
Our unique value creation model, especially Altius Bioventures Racer accelerator program, actively supports our start-ups for higher success rates. Each portfolio company has an ABV Fund partner assigned and our unique team of portfolio advisors significantly adds value to our portfolio.
Our approach emphasizes rigorous methods, validation, and thorough data analysis for evaluating potential investments and managing portfolios. We use a structured process to validate opportunities, employing a robust risk mitigation model.
We emphasize and integrate diversity, equality, and inclusion as core principles within our investment portfolio. Our commitment extends beyond financial metrics, reflecting a conscious effort to support businesses that reflect a rich mosaic of backgrounds and experiences.
120 Lonsdale Avenue, North Vancouver, British Columbia V7L 1B1, Canada
Nous utilisons des cookies pour analyser le trafic du site Web et optimiser votre expérience du site. Lorsque vous acceptez notre utilisation des cookies, vos données seront agrégées avec toutes les autres données utilisateur.